CEOs and scientists on whether existing vaccines will work against Omicron
CBSN
As cases of the Omicron variant continue to rise across the U.S., public health officials have one main question: Are the current COVID-19 vaccines from Moderna, Johnson & Johnson and Pfizer effective against the new variant?
For now, no one truly knows the answer. However, the CEOs of Moderna and Pfizer, as well as scientists from Johnson & Johnson, have all weighed in on the topic. Some say a new vaccine is inevitable, as Omicron can mutate too many different ways; others say they need more data to be sure.
Here's a roundup of what top leaders from vaccine makers have said about their fight against Omicron.

Washington — President Trump said early Monday that he is postponing airstrikes on Iran's power plants after "very good and productive conversations" over the last two days about reopening the Strait of Hormuz. However, Iran's foreign ministry denied any such talks. Claire Day contributed to this report. In:












